Form 10-QSB (Amendment No. 1)


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                              WASHINGTON, DC 20549

     (Mark  One)
(X)     QUARTERLY  REPORT  PURSUANT  TO  SECTION  13  OR  15  (d)
        OF  THE  SECURTIES  EXCHANGE  ACT  OF  1934

For  the  quarterly  period  ended  September  30,  2002
                                    --------------------

(  )    TRANSITION  REPORT  PURSUANT  TO  SECTION  13  OR  15  (d)
        OF  THE  SECURITIES  EXCHANGE  ACT  OF  1934

For  the  transition  period  from  _______________  to  ________________

         COMMISSION FILE NUMBER                  0-30711
                                            -----------------

                            SECURITY BIOMETRICS, INC.
  ----------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

      Nevada                                       88-0209119
     --------                          -----------------------------------
State  or  other  jurisdiction         (IRS  Employer Identification No.)
of  incorporation  or  organization

1410  -  1030  West  Georgia  Street
Vancouver,  British  Columbia,  Canada           V6E  2Y3
(Address  of  principal  executive  offices)    (Zip  Code)

Registrant's  telephone  number,  including  area  code:  (604)  609-7749

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding  12  months  (or  for such shorter period that the registrant was
required  to  file  such  reports),  and  (2)  has  been  subject to such filing
requirements  for  the  past  90  days.

                               Yes  X       No
                                  ----         ---

Indicate  the  number  of  shares outstanding of each of the issuer's classes of
common  stock  as  of  November  5,  2002

Common Stock, $0.001 par value                    119,489,431
------------------------------                    -----------
             Class                              Number  of  shares










<PAGE>
                            SECURITY BIOMETRICS, INC.
                                      INDEX
                                      -----

PART  I

<TABLE>
<CAPTION>


Item  1
Financial Information                               Page No.
--------------------------------------------------  --------
<S>                                                 <C>

Consolidated Balance Sheet September 30, 2002. . .       3-4

Consolidated Statement of Comprehensive Income
 (Loss) for the three month periods ended
 September 30, 2002 & 2001 . . . . . . . . . . . .         5

Consolidated Statements of Operations for the
  three months ended September 30, 2002 & 2001 . .         6

Consolidated Statement of Shareholders' Equity
  for the three months ended September 30, 2002. .         7

Consolidated Statement of Cash Flows for the
  three months ended September 30, 2002 & 2001 . .       8-9

Notes to Consolidated Financial Statements for the
  three month period ended September 30, 2002. . .     10-18

Item 2
Management Discussion and Analysis of Results of
  Operations and Financial Condition . . . . . . .     19-22

Item 3
Controls and Procedures. . . . . . . . . . . . . .     22

Signatures . . . . . . . . . . . . . . . . . . . .     23-26
</TABLE>





















                                                                        PAGE 2
<PAGE>

<TABLE>
<CAPTION>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS

CONSOLIDATED BALANCE SHEET (UNAUDITED)
SEPTEMBER 30, 2002
<S>                                         <C>
ASSETS

CURRENT ASSET
  Cash . . . . . . . . . . . . . . . . . .  $    31,788
  Accounts receivable. . . . . . . . . . .      185,998
  Costs and estimated earnings in excess
     of billings on uncompleted contracts.       31,537
  Inventory. . . . . . . . . . . . . . . .       67,261
  Prepaid expenses . . . . . . . . . . . .      172,922
                                             -----------
                                                489,506
                                             -----------


PROPERTY AND EQUIPMENT,
NET OF ACCUMULATED
DEPRECIATION . . . . . . . . . . . . . . .      228,940
                                             -----------



OTHER ASSETS
  Goodwill . . . . . . . . . . . . . . . .   10,933,298
  Investment in WonderNet, Ltd.. . . . . .      187,500
  Deposits . . . . . . . . . . . . . . . .        5,874
                                             -----------
TOTAL OTHER ASSETS . . . . . . . . . . . .   11,126,672
                                             -----------
TOTAL ASSETS                                $11,845,118
                                             ===========
</TABLE>





                                                                        PAGE 3
<PAGE>

<TABLE>
<CAPTION>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS

CONSOLIDATED BALANCE SHEET (UNAUDITED) (CONTINUED)
SEPTEMBER 30, 2002

<S>                                                 <C>


LIABILITIES

CURRENT LIABILITIES
  Bank overdraft . . . . . . . . . . . . . . . . .  $    70,983
  Accounts payable - non-related parties . . . . .      617,473
  Accounts payable - related parties . . . . . . .      546,148
  Accrued liabilities. . . . . . . . . . . . . . .      344,697
  Corporate income taxes pay.. . . . . . . . . . .      429,471
  Capital lease payable-current portion. . . . . .        5,230
  Notes payable, current portion . . . . . . . . .    2,000,000
  Convertible debentures-current portion . . . . .    1,680,000
  Equipment loan, current portion. . . . . . . . .       15,774
                                                    ------------
TOTAL CURRENT LIABILITIES. . . . . . . . . . . . .    5,709,776
                                                    ------------



LONG-TERM LIABILITIES
  Capital lease - long term portion. . . . . . . .        4,794
  Equipment loan - long term portion . . . . . . .        9,201
  Convertible debenture - long term portion. . . .      100,000
                                                    ------------
TOTAL LONG-TERM LIABILITIES. . . . . . . . . . . .      113,995
                                                    ------------
TOTAL LIABILITIES. . . . . . . . . . . . . . . . .    5,823,771



STOCKHOLDERS' EQUITY
COMMON STOCK
  Authorized - 300,000,000 shares
    $0.001 par value
  Issued and outstanding 119,489,416 shares. . . .      119,489
  Additional paid in capital . . . . . . . . . . .    7,651,168
  Accumulated other comprehensive (loss) . . . . .       (6,169)
  ACCUMULATED DEFICIT. . . . . . . . . . . . . . .   (1,743,141)
                                                    ------------
TOTAL STOCKHOLDERS' EQUITY . . . . . . . . . . . .    6,021,347
                                                    ------------
TOTAL LIABILITIES AND
  STOCKHOLDERS' EQUITY . . . . . . . . . . . . . .  $11,845,118
                                                    ============

<FN>
See  Accompanying  Notes

</TABLE>




                                                                        PAGE 4
<PAGE>
SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENTS  OF  COMPREHENSIVE  INCOME  (LOSS)  (UNAUDITED)

<TABLE>
<CAPTION>


                                                QUARTER         QUARTER
                                                 ENDED           ENDED
                                              SEPTEMBER 30,   SEPTEMBER 30,
                                                 2002            2001
                                              --------------  -------------
<S>                                            <C>            <C>
NET (LOSS). . . . . . . . . . . . . . . . . .  $(185,802)     $(134,873)
  OTHER COMPREHENSIVE INCOME (LOSS)
     Foreign currency translation adjustment.        820         (3,859)
                                               ----------     ----------
NET COMPRENSIVE (LOSS). . . . . . . . . . . .  $(184,982)     $(138,732)
                                               ==========     ==========
</TABLE>





See  Accompanying  Notes







                                                                        PAGE 5
<PAGE>
SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  OPERATIONS  (UNAUDITED)



<TABLE>
<CAPTION>


                                          QUARTER        QUARTER
                                           ENDED          ENDED
                                       SEPTEMBER 30,  SEPTEMBER 30,
                                           2002           2001
                                        -------------  -------------
<S>                                    <C>            <C>
REVENUE
  Contract revenues earned. . . . . .  $    667,534   $         -
  Penflow revenues. . . . . . . . . .        10,000             -
  Datadesk sales. . . . . . . . . . .       102,751             -
  Datadesk royalties. . . . . . . . .        45,150             -
                                       -------------  ------------
TOTAL REVENUE . . . . . . . . . . . .       825,435             -
                                       -------------  ------------



COSTS AND EXPENSES
  Cost of revenues earned . . . . . .       200,962             -
  Cost of sales . . . . . . . . . . .        28,024             -
  Selling general and administrative.       686,734       134,873
                                       -------------  ------------
TOTAL COSTS AND EXPENSES. . . . . . .       915,720       134,873
                                       -------------  ------------


NET OPERATING (LOSS). . . . . . . . .  $    (91,285)  $  (134,873)
  Interest Expense                          (95,517)
                                       -------------  ------------
NET INCOME (LOSS) . . . . . . . . . .      (185,802)     (134,873)
                                       =============  ============

NET (LOSS) PER COMMON SHARE
     Basic and diluted. . . . . . . .  $      (0.00)  $     (0.00)
                                       =============  ============

WEIGHTED AVERAGE NUMBER OF
   COMMON SHARES OUTSTANDING
     Basic and diluted. . . . . . . .   118,853,383    70,935,207
                                       =============  ============
</TABLE>




See  Accompanying  Notes






                                                                        PAGE 6
<PAGE>
SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  STOCKHOLDERS'  EQUITY(UNAUDITED)
FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2002
<TABLE>
<CAPTION>


                                                                  ACCUMULATED
                                                                     OTHER
                                     COMMON  STOCK     ADDITIONAL   COMPRE-
                                     -------------      PAID IN     HENSIVE  ACCUMULATED
                                  SHARES      AMOUNT    CAPITAL     DEFICT     DEFICIT        TOTAL
                                -----------  --------  ----------  --------  ------------  -----------
<S>                             <C>          <C>       <C>         <C>       <C>           <C>
BALANCE, JUNE 30, 2002 . . . .  117,601,248  $117,601  $7,346,645  $(6,989)  $(1,557,339)  $5,899,918

ISSUANCE OF COMMON STOCK FOR:
  Cash . . . . . . . . . . . .      868,168       868     202,743        -             -      203,611
  Services . . . . . . . . . .    1,020,000     1,020     101,780        -             -      102,800

ACCUMULATED OTHER COMPRE-
 HENSIVE (LOSS) FOR THE THREE
 MONTH PERIOD ENDED SEPTEMBER
 30, 2002                                 -         -           -      820             -          820

NET (LOSS) FOR THE THREE MONTH
 PERIOD ENDED SEPTEMBER 30,
 2002                                     -         -           -        -      (185,802)    (185,802)

                                -----------  --------  ----------  --------  ------------  -----------
BALANCE, SEPTEMBER 30, 2002. .  119,489,416  $119,489  $7,651,168  $(6,169)  $(1,743,141)  $6,021,347
                                ===========  ========  ==========  ========  ============  ===========
</TABLE>















                                                                        PAGE 7




















See  Accompanying  Notes

<PAGE>

<TABLE>
<CAPTION>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  CASH  FLOW


                                                             QUARTER       QUARTER
                                                              ENDED         ENDED
                                                           SEPTEMBER 30, SEPTEMBER 30,
                                                                2002        2001
                                                           ------------  -------------

<S>                                                          <C>         <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
  Net (loss). . . . . . . . . . . . . . . . . . . . . . . .  $(185,802)  $(134,873)
  Adjustment to reconcile net (loss) to net cash provided
   (used) by operating activities
      Depreciation. . . . . . . . . . . . . . . . . . . . .     17,830         671
      Consulting services . . . . . . . . . . . . . . . . .    102,800
  Changes in operating assets and liabilities:
      Accounts receivable . . . . . . . . . . . . . . . . .    (71,258)      5,211
      Inventory . . . . . . . . . . . . . . . . . . . . . .     (1,779)          -
      Prepaid expenses and other assets . . . . . . . . . .     16,455         226
      Deposits. . . . . . . . . . . . . . . . . . . . . . .          -         551
      Accrued liabilities . . . . . . . . . . . . . . . . .    (38,993)    (12,950)
      Accounts payable. . . . . . . . . . . . . . . . . . .   (250,812)    (41,646)
      Corporation income taxes payable. . . . . . . . . . .      4,929           -
      Costs and estimated profits in excess of billings on
        uncompleted contracts . . . . . . . . . . . . . . .    (31,537)          -
      Billings in excess of costs and estimated earnings
       on uncompleted contracts . . . . . . . . . . . . . .   (541,245)          -
                                                             ----------  ----------

          NET CASH PROVIDED (USED) BY
          OPERATING  ACTIVITIES . . . . . . . . . . . . . .   (979,412)   (182,810)
                                                             ----------  ----------

CASH FLOWS FROM INVESTING ACTIVITIES:
  Purchase of property & equipment. . . . . . . . . . . . .     (5,220)     (1,838)
                                                             ----------  ----------

          NET CASH PROVIDED (USED)BY
          INVESTING ACTIVITIES. . . . . . . . . . . . . . .     (5,220)     (1,838)
                                                             ----------  ----------

CASH FLOW FROM FINANCING ACTIVITIES:
  Bank overdraft. . . . . . . . . . . . . . . . . . . . . .     70,983
  Proceeds from issuance of common stock. . . . . . . . . .    203,611     189,125
  Payments on capital lease . . . . . . . . . . . . . . . .       (457)     (1,058)
  Payments of equipment note. . . . . . . . . . . . . . . .     (5,103)          -
  Increase in due to related parties. . . . . . . . . . . .    263,291           -

                                                             ----------  ----------
  NET CASH PROVIDED BY FINANCING
   ACTIVITIES . . . . . . . . . . . . . . . . . . . . . . .    532,325     188,067
                                                             ----------  ----------
</TABLE>








                                                                        PAGE 8





<PAGE>
SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  CASH  FLOW
<TABLE>
<CAPTION>


                                             QUARTER       QUARTER
                                              ENDED         ENDED
                                           SEPTEMBER 30, SEPTEMBER 30,
                                              2002          2001
                                           ------------- -------------
<S>                                          <C>         <C>
EFFECT ON EXCHANGE RATE CHANGES ON CASH
     AND CASH EQUIVALENTS . . . . . . . . .  $     820   $(3,859)
                                             ----------  --------

NET INCREASE (DECREASE)  IN CASH AND CASH
     EQUIVALENTS. . . . . . . . . . . . . .   (451,487)     (440)

CASH AND CASH EQUIVALENTS, AT BEGINNING
     OF PERIOD. . . . . . . . . . . . . . .    483,275    26,146
                                             ----------  --------

CASH AND CASH EQUIVALENTS, AT END OF
     PERIOD . . . . . . . . . . . . . . . .  $  31,788   $25,706
                                             ==========  ========

SUPPLEMENTAL DISCLOSURE OF CASH FLOW
     INFORMATION

CASH PAID DURING PERIOD FOR:
      Interest. . . . . . . . . . . . . . .  $  95,517   $     -
                                             ==========  ========

      Taxes . . . . . . . . . . . . . . . .  $       -   $     -
                                             ==========  ========

NON-CASH INVESTING AND FINANCIAL ACTIVITIES  $       -   $     -
                                             ==========  ========

ISSUANCE OF COMMON STOCK FOR:
       Services . . . . . . . . . . . . . .  $ 102,800   $     -
                                             ==========  ========
</TABLE>





                                                                        PAGE 9








See  Accompanying  Notes

<PAGE>
SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS
SEPTEMBER  30,  2002

NOTE  1     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES

ORGANIZATION  AND  NATURE  OF  BUSINESS
---------------------------------------

SECURITY  BIOMETRICS,  INC.  AND  BIOMETRICS  SECURITY,  INC.

Security  Biometrics,  Inc. (hereinafter referred to as the Company) is a Nevada
corporation  incorporated  on  March  12,  1999.

On August 25, 2000, the Company acquired all of the issued and outstanding stock
of  Biometrics  Security,  Inc. (hereinafter referred to as BSI) in exchange for
38,257,675 shares of its common stock. (37,500,000 of these shares were owned by
a  trust  whose  beneficiaries  were  the  children  of  a former officer of the
Company).

This  transaction  has  the effect of what is commonly referred to as a "reverse
acquisition"  in  that  the  Company  is the legal acquirer; however, BSI is the
accounting  acquirer.

In  connection  with  the  legal  form  of  this  transaction,  BSI  became  a
wholly-owned  subsidiary  of  the  Company.  For  accounting  purposes,  the
acquisition  is  treated  as  a  recapitalization  of BSI rather than a business
combination.

BASIS  OF  PRESENTATION

The unaudited financial statements of Security Biometrics, Inc. (The Company) as
of September 2002 and 2001 and for the three months ended September 30, 2002 and
2001  have  been  prepared  in  accordance  with accounting Principles generally
accepted  in  the United States for interim reporting.  Accordingly, they do not
include  all  of  the  disclosures  required  by accounting principles generally
accepted  in  the  United  States  for  complete  financial statements and notes
thereto  included in the company's form 10-KSB for the year ended June 30, 2002.
In  the  opinion  of  management,  all  adjustments  (consisting  only of normal
recurring  adjustments)  considered  necessary  for  a  fair presentation of the
interim  financial information have been included. The results of operations for
any  interim  period are not necessarily indicative of the results of operations
for  the  entire  year.

GOING  CONCERN

The  Company  experienced  significant  operating  losses  since  inception.  In
addition,  the  Company has a working capital deficit amounting to $5.2 million.
The  financial  statements have been prepared assuming the Company will continue
to  operate  as a going concern which contemplates the realization of assets and
the  settlement  of liabilities in the normal course of business.  No adjustment
has  been  made  to  the  recorded  amount  of  assets or the recorded amount or
classification of liabilities which would be required if the Company were unable
to  continue  its operations.  As discussed in Note 16, management has developed
an  operating  plan which they believe will generate sufficient cash to meet its
obligations  in  the  normal  course  of  business.

PRINCIPLES  OF  CONSOLIDATION

The  consolidated  financial  statements  include  the  accounts  of  Security
Biometrics,  Inc.  and  the  following  wholly  owned  subsidiaries:


     Biometrics  Security,  Inc.
     Lightec  Communications  Corp.
     Datadesk  Technologies,  Inc.

     All material inter-company accounts and transactions have been eliminated.


                                                                        PAGE 10

<PAGE>
------
SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS
SEPTEMBER  30,  2002


NOTE  1     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES  (CONTINUED)


CASH  AND  CASH  EQUIVALENTS

For  purposes  of  the statement of cash flows, the Company considers all highly
liquid  debt  instruments purchased with an original maturity of three months or
less  to  be  cash  equivalents.

ACCOUNTING  ESTIMATES
---------------------

Management  uses  estimates and assumptions in preparing financial statements in
accordance  with  generally accepted accounting principles.  Those estimates and
assumptions  affect  the  reported  amounts  of  assets  and  liabilities,  the
disclosure  of  contingent assets and liabilities, and the reported revenues and
expenses.  Actual  results  could  vary  from  the  estimates  that  were  used.



REVENUE  AND  COST  RECOGNITION
-------------------------------

LIGHTEC
-------

Lightec  recognizes  revenues  from  fixed-price  and  modified  fixed-price
construction  contracts  on the percentage-of-completion method, measured by the
percentage  of  cost incurred to date to estimated total cost for each contract.
That  method  is  used  because  management  considers total cost to be the best
available  measure  of  progress  on  the  contracts.  Because  of  inherent
uncertainties  in  estimating costs, it is at least reasonably possible that the
estimates  used  will  change  within  the  near  term.

Revenue from time-and-materials contracts is recognized currently as the work is
performed.

Contract  costs  include  all direct material and labor costs and those indirect
costs  related to contract performance, such as indirect labor, supplies, tools,
repairs,  and  depreciation.  Selling,  general,  and  administrative  costs are
charged  to expense as incurred.  Provisions for estimated losses on uncompleted
contracts  are  made in the period in which such losses are determined.  Changes
in  job  performance,  job conditions, and estimated profitability may result in
revisions  to  costs and income, which are recognized in the period in which the
revisions are determined.  Changes in estimated job profitability resulting from
job  performance,  job  conditions,  contract  penalty  provision, claims change
orders and settlements, are accounted for as changes in estimates in the current
period.

The  asset,  "Costs  and estimated earnings in excess of billings on uncompleted
contracts,"  represents  revenues  recognized  in excess of amounts billed.  The
liability,  "Billings  in  excess of costs and estimated earnings on uncompleted
contracts,"  represents  billings  in  excess  of  revenues  recognized.

Revenue  from  claims  is recognized when realization is probable and the amount
can  be reliably estimated.  When realization is probable, but the amount cannot
be  reliably  estimated,  revenue is recognized to the extent of costs incurred.

DATADESK
--------

Product  sales  -  when  goods  are  shipped  and  title passes to the customer.

Keyboard  development  fees  -  when  services  are  performed.

Royalties  -  when  the  licensee  sells the product and reports the sale to the
Company.


                                                                        PAGE 11
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS
SEPTEMBER  30,  2002

NOTE  1     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES  (CONTINUED)

ACCOUNTS  RECEIVABLE
--------------------

Accounts receivable are reported at the customers' outstanding balances less any
allowance  for  doubtful  accounts, marketing credits and allowance for possible
sales  returns.

ALLOWANCE  FOR  DOUBTFUL  ACCOUNTS, MARKETING CREDITS AND ALLOWANCE FOR POSSIBLE
--------------------------------------------------------------------------------
SALES  RETURNS
--------------

The  allowance  for doubtful accounts is charged to income in amounts sufficient
to  maintain  the  allowance at a level management believes is adequate to cover
any  possible  losses,  credits  or  returns.

INVENTORY
---------

Datadesk's inventory is stated at the lower of cost (determined on the first-in,
first-out  method)  or  market.

PROPERTY  AND  EQUIPMENT
------------------------

Property  and equipment are stated at cost.  Major renewals and improvements are
charged to the asset accounts while replacements, maintenance and repairs, which
do  not  improve or extend the lives of the respective assets, are expensed.  At
the  time property and equipment are retired or otherwise disposed of, the asset
and  related  accumulated  depreciation  accounts are relieved of the applicable
amounts.  Gains  or  losses from retirements or sales are credited or charged to
income.

The  Company  depreciates  its  property  and  equipment for financial reporting
purposes using the straight-line method based upon the following useful lives of
the  assets:

      Furniture  and  fixtures         7-10  Years
      Machinery  and  equipment        5     Years
      Computer  equipment              5     Years
      Vehicles                         5     Years

ACCOUNTING  FOR  CONVERTIBLE  DEBT  SECURITIES
----------------------------------------------

The  Company  has  issued  convertible  debt  securities  with  a non-detachable
conversion  feature  that were "in the money" at the date of issue.  The Company
accounts for such securities in accordance with Emerging Issues Task Force Topic
98-5.  The  Company  has  recorded  the  fair value of the beneficial conversion
feature  as  interest  expense  and  an  increase  in Additional Paid-In Capital

The  beneficial  interest  is computed by subtracting the stock conversion price
from  the  market  price  of  the  stock times the number of shares and warrants
eligible  for  conversion.

INCOME  TAXES
-------------

Provisions  for  income  taxes  are based on taxes payable or refundable for the
current  year  and deferred taxes on temporary differences between the amount of
taxable  income  and pretax financial income and between the tax basis of assets
and  liabilities  and  their  reported  amounts  in  the  financial  statements.
Deferred  tax assets and liabilities are included in the financial statements at
currently  enacted  income  tax  rates  applicable  to  the  period in which the
deferred  tax  assets  and liabilities are expected to be realized or settled as
prescribed  in  FASB Statement No. 109, Accounting for Income Taxes.  As changes
in  tax  laws  or  rates  are  enacted,  deferred tax assets and liabilities are
adjusted  through  the  provision  for  income  taxes.

                                                                        PAGE 12
<PAGE>
SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS
SEPTEMBER  30,  2002

NOTE  1     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES  (CONTINUED)


NET  (LOSS)  PER  SHARE
-----------------------

The  Company  adopted  Statement  of Financial Accounting Standards No. 128 that
requires the reporting of both basic and diluted (loss) per share.  Basic (loss)
per share is computed by dividing net (loss) available to common stockholders by
the  weighted  average  number  of  common  shares  outstanding  for the period.
Diluted  (loss)  per  share  reflects the potential dilution that could occur if
securities  or other contracts to issue common stock were exercised or converted
into  common stock. In accordance with FASB 128, any anti-dilutive effect on net
(loss)  per  share  are  excluded.

LONG-LIVED  ASSETS
------------------

Statement  of  Financial  Accounting  Standards  No.  121,  "Accounting  for the
Impairment  of  Long-lived  Assets  and for Long-Lived Asset to be Disposed Of,"
requires  that  long-lived  assets be reviewed for impairment whenever events or
changes  in  circumstances  indicate  that  the  carrying amount of the asset in
question  may  not be recoverable.  This standard did not have a material effect
on  the  Company's  results  of  operations,  cash  flows or financial position.

DISCLOSURE  ABOUT  FAIR  VALUE  OF  FINANCIAL  INSTRUMENTS
----------------------------------------------------------

The  Company  estimates  that  the fair value of all financial instruments as of
September  30, 2002, as defined in FASB 107, does not differ materially from the
aggregate  carrying  values  of  its  financial  instruments  recorded  in  the
accompanying  balance  sheet.  The  estimated  fair  value  amounts  have  been
determined  by  the  Company  using available market information and appropriate
valuation  methodologies.  Considerable  judgment  is  required  in interpreting
market  data  to  develop  the  estimates  of  fair  value, and accordingly, the
estimates  are  not necessarily indicative of the amounts that the Company could
realize  in  a  current  market  exchange.

FOREIGN  CURRENCY  TRANSLATION
------------------------------

The  financial  statements  of  the Company are measured using the United States
dollar  as  the functional currency.  Assets, liabilities and equity accounts of
the  Company  are  translated from foreign currency to United States currency at
exchange  rates  as  of  the  balance sheet date or historical acquisition date,
depending on the nature of the account.  Revenues and expenses are translated at
average  rates  of exchange in effect during the year.  The resulting cumulative
translation  adjustments  have  been  recorded  as  a  separate  component  of
stockholders'  equity.

SHIPPING  AND  HANDLING  COSTS
------------------------------

The  Company's policy is to classify shipping and handling costs as part of cost
of  goods  sold  in  the  statement  of  operations.

NOTE  2     CASH  IN  BANK

     The  Federal  Deposit  Insurance  Corporation  and  the Securities Investor
Protection Corporation insure up to $100,000 for approved deposits in registered
financial institutions.  The Company had no  uninsured deposits at September 30,
2002.

                                                                        PAGE 13


<PAGE>
SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS
SEPTEMBER  30,  2002

NOTE  3     ACCOUNTS  RECEIVABLE


A summary of accounts receivable is as follows:

<TABLE>
<CAPTION>
<S>                                                       <C>

Account Receivable . . . . . . . . . . . . . . . . . . .  $194,248
Less allowance for doubtful accounts, sales returns, and
  advertising incentives . . . . . . . . . . . . . . . .    (8,250)
                                                          ---------
Total accounts receivable. . . . . . . . . . . . . . . .  $185,998
                                                          =========
</TABLE>







NOTE  4   INVENTORY

Inventory  is  comprised  of  the  following:

<TABLE>
<CAPTION>
<S>                                      <C>
   Finished goods . . . . . . . . . . .  $49,119
   Raw materials. . . . . . . . . . . .   22,142
                                         --------
                                          71,261
   Allowance for inventory obsolescence   (4,000)
                                         --------
Total inventory . . . . . . . . . . . .  $67,261
                                         ========
</TABLE>


NOTE  5     PREPAID  EXPENSES

Prepaid  expenses  are  being amortized on a straight line basis over a one year
period.


NOTE  6     PROPERTY  AND  EQUIPMENT

Property  and  equipment  and  accumulated  depreciation  consists  of:

<TABLE>
<CAPTION>
<S>                               <C>
   Furniture and fixtures. . . .  $ 97,789
   Machinery and equipment . . .   125,680
   Computer equipment. . . . . .    96,414
   Vehicles. . . . . . . . . . .   103,902
                                  --------
                                   423,785
   Less accumulated depreciation   194,845
                                  --------
Total Property & Equipment . . .  $228,940
                                  ========
</TABLE>

                                                                        PAGE 14
<PAGE>
SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS
SEPTEMBER  30,  2002

NOTE  7      GOODWILL

The  Company adopted the provisions of FASB 142 for the accounting for goodwill.
According  to  the FASB requirements, goodwill is capitalized and not amortized.
Each  year,  management is required to review goodwill to determine if there has
been  an  impairment  loss  to  recognize  on  the  carrying  value of goodwill.
Management  believes  that there has been no impairment loss on goodwill for the
three  months  ended  September  30,  2002

Goodwill  is  comprised  of  the  following:

The  excess  of  the  cost  of  an  acquired  entity over the net of the amounts
assigned  to  assets  acquired  and  liabilities  assumed  for:

                                                     Lightec     $     7,527,653
                                                     Datadesk          3,405,645
                                                                       ---------
                                                                 $    10,933,298
                                                                 ===============


NOTE  8       ESTIMATED  EARNINGS  ON  UNCOMPLETED  CONTRACTS

<TABLE>
<CAPTION>

<S>                                                   <C>
Costs incurred on uncompleted contracts. . . . . . .  $23,653
Estimated earnings . . . . . . . . . . . . . . . . .    7,884
                                                      -------
                                                       31,537
Less: Billings to date . . . . . . . . . . . . . . .        -
                                                      -------
Costs in excess of billings on uncompleted contracts  $31,537
                                                      =======
</TABLE>


NOTE  9     CAPITAL  LEASE  PAYABLE

BSI  acquired  an  office copier on a capital lease with National Leasing Group,
Inc.  The  lease  requires  monthly payments of approximately $300 for 48 months
including  interest  at  11%.  Future  minimum  payments  are  as  follows:

                                  September  30,  2003      $     5,230
                                  September  30,  2004            4,794
                                                                 ------
            Total  minimum  lease  payments                      10,024
            Less  amount  representing  interest                  1,634
                                                                  -----
            Present  value  of  minimum  lease  payment     $     8,390
                                                            ===========

                                                                        PAGE 15
<PAGE>
SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS
SEPTEMBER  30,  2002

NOTE  10     NOTES  PAYABLE

<TABLE>
<CAPTION>



<S>                                                                           <C>
                                                                              SEPTEMBER 30,
                                                                              --------------
                                                                                    2002
                                                                              --------------
MARYANNE RICHARD                                                              $    1,000,000
On June 13, 2002, the Company issued a note payable to Maryanne
Richard in the amount of $1,000,000 as part of the consideration for
the purchase of Lightec. The note bears interest at 9% and requires
250,000 principal payments on December 31, 2002, March 31, 2003
and a final $500,000 payment on June 30, 2003.  The note is secured
by deposit accounts, investment property, letters of credit rights and
letters of credit, rights to payments evidenced by chattel paper, rights to
payments for money or funds advanced or sold and all proceeds of any
and all of the above.  The collateral for this security at September 30,
2002 amounted to $1,525,255.  The security is co-equal to in priority to
the security granted for the $1,000,000 note payable to Synergex
Group. Consideration of 8,000,000 share purchase warrants which
gives the rights to the holder to acquire one share of common stock at a
price of $0.125 for a period of two years was given to extend the
repayment terms by three months to commence on December 31, 2002
The granting of share purchase warrants is subject to Lightec obtaining
funding on the Bridgeport contract.

SYNERGEX GROUP PARTNERSHIP

On June 11, 2002, Synergex Group Partnership loaned the Company                1,000,000
1,000,000 to facilitate the acquisition of Lightec. The note bears
interest at 9% and requires $250,000 principal payments on, December
31, 2002, January 31, 2003, February 28, 2003 and March 31, 2003.
The note is secured by deposit accounts, investment property, letters of
credit rights and letters of credit, rights to payments evidenced by
chattel paper, rights to payments for money or funds advanced or sold
and all proceeds of any and all of the above.  The collateral for this
security at September 30, 2002 amounted to $1,525,255.  The security
is co-equal in priority to the security granted for the $1,000,000 note
payable to Mary Anne Richard. Consideration of 8,000,000 share
purchase warrants which gives the rights to the holder to acquire one
share of common stock at a price of $0.125 for a period of two years
was given to extend the repayment terms by three months to commence
on December 31, 2002 The granting of share purchase warrants is
subject to Lightec obtaining funding on the Bridgeport contract.
                                                                              --------------
                                                                              $    2,000,000
                                                                              ==============
</TABLE>




                                                                        PAGE 16

<PAGE>
SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS
SEPTEMBER  30,  2002

NOTE  11     NOTES  PAYABLE,  EQUIPMENT

<TABLE>
<CAPTION>

<S>                                                           <C>
Payable to General Motors Acceptance Corporation, secured
 by two 2001 GMC Savanas with original costs of $46,864;
 payable for 36 months at $1,316 per month including interest
 at 4.9% . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  $24,975
Less current portion . . . . . . . . . . . . . . . . . . . . . . . .   15,774
                                                                      -------
Long-term portion. . . . . . . . . . . . . . . . . . . . . . . . . .    9,201
                                                                      =======
</TABLE>

   Principal  maturities  are  as  follows:
             September  30,  2003                             $15,774
             September  30,  2004                               9,201
                                                                -----
                                                              $24,975
                                                              =======


NOTE  12     CONVERTIBLE  DEBENTURE  PAYABLE

<TABLE>
<CAPTION>



<S>                                                                <C>
LIBRICO PROPERTIES, LTD.
                                                                   $  100,000
On November 8, 2001, the Company issued a convertible
debenture to Librico Properties, Ltd. for a minimum of
100,000 to a maximum of $1,000,000.

The debenture is unsecured, bears interest at 12% and
matures on November 2, 2011.

Librico Properties, Ltd. has the option, in whole or in part, to
convert the debenture into the Company's common stock at a
conversion price of $0.33 per share, subject to anti-dilution
adjustments.

EDINBURGH INVESTMENTS LLC
                                                                    1,680,000
On June 30, 2002, the Company issued a convertible
debenture to Edinburgh Investments LLC.  The debenture is
unsecured, matures on June 30, 2003 and accrues interest at
10% payable quarterly.  September  30,  2002  payments  are
currently  in  arrears. Edinburgh has the option to convert
the debenture into the Company's common stock at a
conversion price of $.30 per share, subject to anti-dilution
adjustments.

                                                                   ----------
                                                                    1,780,000
                Less current portion. . . . . . . . . . . . . . .   1,680,000
                                                                   ----------
                Long-term portion . . . . . . . . . . . . . . . .  $  100,000
                                                                   ==========

Future maturities on the long-term debt are as follows:
                    September 30, 2003. . . . . . . . . . . . . .  $1,680,000
                    June 30, 2012 . . . . . . . . . . . . . . . .     100,000
                                                                   ----------
                                                                   $1,780,000
                                                                   ==========
</TABLE>

                                                                        PAGE 17
<PAGE>
SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS
SEPTEMBER  30,  2002

NOTE  13  STOCK  WARRANTS

The  company  has  the  following  warrants  outstanding:
        NUMBER  OF          PRICE               EXPIRATION
          SHARES          PER  SHARE               DATE
          ------          ----------               ----

        7,083,333         $     0.35         June  13,  2005

The Company has the right to force convert of the warrants if the stock price of
the  shares  exceeds  $1.20  for  a  ninety  day  period.

The  Company  is  in the process of issuing additional warrants in consideration
for  extension  agreements  on the Notes Payable for 16,000,000 shares at $0.125
per  share  for  a  period  of  one  year.  (see  Note  10)

NOTE  14  SHARE  SUBSCRIPTIONS

The following schedule summarized the features and status of the current private
placement  offering

<TABLE>
<CAPTION>
<S>                                                          <C>
Total offering. . . . . . . . . . . . . . . . . . . . . . .  1,000,000 shares at $0.15 per share ($150,000)

Private placement unit. . . . . . . . . . . . . . . . . . .  Each unit consists of 10,000 shares and 5,000 share
                                                             purchase warrants entitling the holder to purchase an
                                                             additional 5,000 shares at $0.15 for a period of 6 months
                                                             after the private placement closed November  11,  2002.
..

Status as of September 30, 2002 . . . . . . . . . . . . . .  11.5 units sold raising $114,561 funds less $6,500
                                                             finders fees.

</TABLE>


NOTE  15     BUSINESS  SEGMENTS

FASB  Statement  No. 131 "Disclosure about Segments of an Enterprise and Related
Information,"  requires  companies  to  provide  certain information about their
operating  segments.  The  Company  has  three  reportable  segments:  Biometric
Technologies,  Lightec  and  DataDesk.

Summarized financial information concerning the Company's reportable segments is
shown  on  the  following  table:

<TABLE>
<CAPTION>

<S>                               <C>           <C>        <C>        <C>
                                    BIOMETRIC
                                    TECHNOLOGY    LIGHTEC    DATADESK   TOTAL
                                  ------------  ---------  ---------  -----------
Net sales to external companies.  $    10,000     667,534   147,901      825,435
Operating earnings (loss). . . .     (335,096)    323,922   (79,111)     (90.285)
Total assets . . . . . . . . . .   10,120,305   1,525,525   199,288   11,845,118
Depreciation and amortization. .        1,920      12,627     3,283       17,830
Capital expenditures . . . . . .          661       1,962     2,597        5,220
</TABLE>

NOTE  16     MANAGEMENTS  PLANS

Of  the  $5,220,270 working capital deficit, approximately $2,546,148 is owed to
related  parties.  The  Company plans restructure its financial position through
continued  Lightec  Communication  sales  to  its  existing  and  new customers;
sublicensing of Penflow technology to vertical software integrators; and through
the  development  and  sale  of proprietary technology of the Datadesk division.
The  Company  also  plans to raise additional capital by way of debt, equity and
shareholder  loans.

                                                                        PAGE 18
<PAGE>
ITEM  2.     MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OR  PLAN  OF  OPERATIONS

Critical  Accounting  Policies
------------------------------

Our discussion and analysis of our financial condition and results of operations
are  based  upon  our  consolidated  statements,  which  have  been  prepared in
accordance  with  accounting principles generally accepted in the United States.
The  preparation of these financial statements requires us to make estimates and
judgments  that affect the reported amounts of assets, liabilities, revenues and
expenses.  In  consultation  with our Board of Directors and Audit Committee, we
have  identified  two   accounting  policies   that  we  believe  are  key to an
understanding  of  our  financial  statements.  These  are  important accounting
policies  that  require  management's  most  difficult,  subjective  judgments.

The  first  critical  accounting  policy  relates  to  revenue  recognition.  We
recognize  revenue  from  product  sales  upon shipment to the customer. License
revenues  are recognized when earned, in accordance with contractual provisions.
Royalty  revenues  are  recognized  upon  shipment of products incorporating the
related technology by the original equipment manufacturers (OEMs) and foundries.

The  second  critical  accounting  policy  relates  to  intangible  assets.  Our
intangible  assets  consist  primarily of goodwill. In accordance with SFAS 142,
"Goodwill  and  Other  Intangible  Assets," only intangible assets with definite
lives  are  amortized.  Non-amortized  intangible  assets are instead subject to
annual  impairment  testing.

History
-------

When  used  in  this Form 10-QSB, the words "anticipated", "estimate", "expect",
and  similar  expressions  are  intended to identify forward-looking statements.
Such  statements  are  subject  to  certain risks, uncertainties and assumptions
including the possibility that we will fail to generate planned revenues. Should
one  or  more  of these risks or uncertainties materialize, or should underlying
assumptions  prove  incorrect,  actual  results  may  vary materially from those
anticipated,  estimated  or  projected.

The  following  discussion  and  analysis of financial conditions and results of
operation  should  be  read  in  conjunction  with  our  consolidated  financial
statements  and  notes  thereto  included  elsewhere  in  this  Form  10-QSB.

Security  Biometrics, Inc. was incorporated as Great Bear Resources, Inc. in the
State  of  Nevada  on  March  12,  1999  and  we  changed our name to Great Bear
Investments,  Inc.  on  May 25, 1999. On August 11, 2000, we changed our name to
Security  Biometrics,  Inc.  We were a development state company whose objective
was  to  develop,  market  under  license  and  distribute  dynamic  biometric
technologies  specific  to  the  security  applications of banking and financial
transactions,  including  dynamic  gesture  recognition  technology,  dynamic
signature  verification  and  voice  recognition.

On  August  22,  2000,  we entered into an option agreement with DSI Datotech of
Vancouver,  Canada. The exercise price of the option was $8,000,000, of which we
paid  $320,000.  On June 29, 2001, we acquired all of the outstanding membership
interests  of NetFace, LLC, a Connecticut limited liability company, in exchange
for  20,000,000 share of our common stock. NetFace holds an option to acquire an
exclusive  worldwide,  perpetual,  royalty-free license to exploit DSI's gesture
recognition  technology  for  video  games and Internet/television. The exercise
price  of  the  option  is  $5,000,000 plus a 20% Class B Membership of NetFace.
During  the year ended June 30, 2002, it was decided to abandon our interests in
DSI's  technology.

On  April  20,  2002, the Company entered into an exclusive rights and licensing
distribution and partnership agreement with WonderNet Ltd. of Israel. Under this
agreement,  we became the exclusive distributor for North America, the Caribbean
and  Mexico  of  WonderNet's  Penflow(TM)  patented  and  proprietary  Biometric

                                                                        PAGE 19
<PAGE>
Signature  Authentication  ("BSA") software engine, which consists of a database
of  user  profiles  and enable remote and local access to the database using the
internet,  smart cards, or LAN connections to verify signatures by comparison to
said  database. To acquire these rights, we issued WonderNet 2,500,000 shares of
common  stock and agreed to pay WonderNet a 5 per cent royalty on products sold.

The  agreement  with  WonderNet allows us to commence sub-licensing, marketing a
proven  biometric  security  product.  We  have  decided to not to exercise  our
options  with DSI Datotech at this time as we do not believe that the prototypes
delivered  to  us  are  market  ready  at  this  time. Consequently, the Company
expensed $320,000 in 2001 and the balance of the investment of $200,000 in 2002.

In  order  to  assist  in  the  development  and  support of providing biometric
security  solutions,  we  entered  into an agreement effective March 14, 2002 to
acquire  the  issued  and outstanding shares of Lightec Communications, Corp. of
Pleasant  Valley,  New  York.  Lightec  is  a  provider  of  high  quality
telecommunications  design,  installation  and  information technology services.
Lightec  was  established  in  1994  and  provides  quality  network  design,
installation,  and  maintenance  of  internal  building,  campus-wide,  local,
metropolitan  and  wide  area  network systems, in primarily in the northeastern
United  States.  On June 14, 2002, we closed the agreement to acquire Lightec by
issuing  19,000,000  shares  of  common  stock and paying $4,000,000 in cash. In
connection  with this acquisition, we issued 4,000,000 in shares of common stock
and  accrued $200,000 as finder's fees under a finder's fee agreement with Chris
Farnworth.

On  June  28,2002  we  entered  into  an  agreement  to  acquire  the issued and
outstanding  shares  of  Datadesk  Technologies,  Inc.  of  Seattle, Washington.
Datadesk  is  in  the  business of designing, manufacturing, and selling desktop
solutions,  educational  computing  systems,  and handheld and wireless devises.
Datadesk  was  established  in  1997  and  provides  high  quality  key  boards,
peripheral  devises,  and  educational  systems.  On June 28,2000, we closed the
agreement to acquire Lightec by issuing 10,999,951 shares of common stock and by
lending  $1,260,200  cash  to  Datadesk.

 Until  the  acquisition  of Lightec, we were a development stage company. As of
March  14,  2002,  with  the  acquisition of Lightec we have become an operating
company.  During  the three months ended September 30, 2002 ("YTD2003"), our net
loss was $186,000 as compared to a $129,000 loss incurred during the three month
period  ended  September  30,  2001  ("YTD2002"), as explained in the results of
operations.

RESULTS  OF  OPERATIONS  YTD2003  AS  COMPARED  TO  YTD2002

During  the  YTD2003  we  have incorporated the financial results of Lightec and
Datadesk. Comparative numbers do not reflect the results of these companies. The
following  schedule  highlight  and  provides  explanations  to  the significant
changes  incurred  during  the  year:

<TABLE>
<CAPTION>
                          Increase
                         (decrease)
Income Statement         during the
Item                        Year      Explanation
<S>                     <C>           <C>
----------------------  -----------   -------------------------------------
Contract revenues. . .  $   668,000   Billings made in excess of costs And
earned                                Expected profits totaling $541,000
                                      were realized during YTD2003.
Pen flow sales . . . .       10,000   Represents revenues from sale of
                                      Penflow products
Datadesk sales and . .      148,000   Represent revenues by Datadesk
royalties
Cost of revenues . . .      201,000   Direct expenses incurred earning
earned                                Lightec revenues
Cost of sales. . . . .       28,000   Represent direct costs of
                                      Datadesk sales
Interest expense . . .       96,000   Increase is due to $3.8 million
                                      in loans outstanding
Selling, general &
administrative as
follows:
- Communication Costs.       43,000   Increase is due to costs of 3
                                      offices versus 1 during prior
                                      year
</TABLE>
                                                                        PAGE 20
<PAGE>
<TABLE>
<CAPTION>
<S>                     <C>           <C>
- Employee costs . . .      197,000   Lightec and Datadesk operations
- Investor relations .       25,000   Increased investor relation activities
- Marketing. . . . . .       33,000   Marketing costs of biometric and
                                      Datadesk products
- Office . . . . . . .       35,000   Increase office expenses due to
                                      costs of keeping 3 offices supplied
- Consulting . . . . .      150,000   Increase due to effect of hiring
                                      COO, CFO and VPs.
- Regulatory Costs . .        8,000   Due to costs of Edgar filings.
- Research & . . . . .       46,000   Increase is due to Datadesk R & D
   Development                        work
- Premise costs. . . .       30,000   Increase is having 3 offices
- Legal. . . . . . . .      (30,000)  Reduced costs due to reduced going
                                      public costs
Other expenses . . . .       15,000
Increased Selling, . .      552,000
general &
administration
expenses
Increase (decrease). .      (51,000)
in loss in quarter
ended September 30th
2002 over 2001
</TABLE>
         At  September  30,  2002,  shareholder  equity  totaled  $6,021,347

LIQUIDITY  AND  CAPITAL  RESOURCES

During  the  YTD2003  as  compared  to  YTD2002,  our  cash  flow  provided from
operations decreased by almost $822,000 to $979,000 at September 30, 2002 from a
negative  $157,000  as  at  September 30, 2001. This decrease was due to reduced
accounts  payable  of $251,000, increased costs and estimated earnings in excess
of billings on uncompleted contracts and reduced billings in excess of costs and
estimated  earning  of  $541,000.

Over  75% of the revenues generated by Lightec in prior years was from one major
contract. In the current year, delays in funding by Lightec's major customer has
resulted  in  a  marked  slow  down  in  revenue  generation  by  Lightec. It is
anticipated  that  the major customer will get its legislated funding during the
current  quarter,  or  at  the  latest  the  following  quarter.

At  September  30,  2002,  we  had  negative  working  capital  of approximately
$5,200,000.  We will require additional financing over the next twelve months to
fund  our  operations  and satisfy our debt service obligations. We financed the
acquisitions  of  Lightec  and  Datadesk,  in  part, though the sale of our debt
securities. We are obligated to repay $2,000,000 in loans to finance the Lightec
acquisition.  Because  of delays in funding by Lightec's major customer, we have
worked  with  the  lenders and have delayed repayment  for an additional 3 month
period  to  a  six month period commencing December 31, 2002. The payment of the
10%  convertible  debentures  in the principal amount of $1,680,000 we issued in
connection with the acquisition of Datadesk is due in June 2003. Payments of the
notes  issued  in  connection  with  the  Lightec acquisition are secured by the
assets  of Lightec. If we are unable to generate substantial cash flows from the
operations  of  Lightec  and  Datadesk,  and  obtain  additional  financing,  or
restructure  the  indebtedness  relating  to  the  acquisitions,  our ability to
continue  the  operation  of  these  acquired  businesses  and  expand our other
biometric  security  activities  may  be  severely  impaired.

FORWARD  LOOKING  STATEMENTS
----------------------------

The  forgoing  Management's  Discussion  and  Analysis  contain forward -looking
statements  within  the  meaning  of Rule 175  of the Securities Act of 1933, as
amended,  and  Rule  3b-6  of the Securities Act of  1934, as amended, including
statements  regarding,  among other items, the Registrant's business strategies,
continued  growth  in  the  Registrant's  markets,  projections, and anticipated
trends  in  the Registrant's business and the industry in which it operates. The
words  believe,  expect,  anticipate,  intends,  forecast,  project, and similar
expression identify forward-looking statements. These forward-looking statements
are  based  largely on the Registrant's expectations and are subject to a number
of  risks  and  uncertainties,  certain  of  which  are  beyond the Registrant's
control.  The  factors that could cause actual results to differ materially form
those  in the forward looking statement, including, among others, the following:
reduced  or lack of increase in demand for the Registrant's products or proposed

                                                                        PAGE 21
<PAGE>
products,  competitive  pricing  pressures,  changes  in  the  market  price  of
ingredients used in the Registrant's products and the level of expenses incurred
in  the Registrant's operation. In light of these risks and uncertainties, there
can  be  no assurance that the forward-looking information contained herein will
in  fact  transpire or prove to be accurate. The Registrant disclaims any intent
or  obligation  to  update  forward  looking  statements.

ITEM  3  -  CONTROLS  AND  PROCEDURES

Within  90  days  prior  to the filing of this report, the Company's management,
including  the  Company's  Chief  Executive Officer and Chief Financial Officer,
evaluated  the  effectiveness of the design of the Company's disclosure controls
and procedures, as defined in Rule 13a-14(c) under the Security and Exchange Act
of  1934.  Based  on  that evaluation, the Chief Executive Officer and the Chief
Financial  Officer  concluded  that   the  Company's  disclosure   controls  and
procedures  were  effective,  in  all  material  respects,  to  ensure  that the
information  required  to  be  disclosed  in  the  reports the Company files and
submits  under  the Exchange Act is recorded, processed, summarized and reported
as  and  when  required.

There  have  been  no  significant  changes  (including  corrective actions with
regards  to  significant  deficiencies and material weaknesses) in the Company's
internal controls or in other factors subsequent to the date the Company carried
out  its  evaluation  that  could  significantly  affect  these  controls.


PART  II  -  OTHER  INFORMATION

Items  No.  1,  2,  3,  4,  and  5  -  Not  Applicable

Item  No.  6  -  Exhibits  and  Reports  on  Form  8-K  -  none








                                                                        PAGE 22

<PAGE>
                                   SIGNATURES

In  accordance  with  Section  13  or 15 (d) of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                              By:  /s/  Kenneth  Barr
                              -----------------------
                              Name:  Kenneth  Barr
Date:  November 12, 2002                    Title: President and Chief Executive
Officer

                              By:  /s/David  Alexander
                              ------------------------
                              Name:  David  Alexander
Date:  November  12,  2002                    Title:  Chief  Financial  Officer






                                                                        PAGE 23
<PAGE>

                             CERTIFICATE PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                               SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

In  connection  with  the  Quarterly Report of Security  Biometrics,  Inc., (the
"Company")  on  Form 10-QSB for the three month period ended September 30, 2002,
as  filed  with  the  Securities and Exchange Commission on the date hereof (the
"Report"), we certify pursuant to 18 U.S.C. (S) 1350, as adopted pursuant to (S)
906  of  the  Sarbanes-Oxley  Act  of  2002,  that:

     1. The Report fully complies with the requirements of Section 13 (a) of the
        Securities  Exchange  Act  of  1934;  and

     2. The information contained in the Report fairly presents, in all material
        respects, the  financial  condition  and   results of  operation  of the
        Company.




Date:  November  12,  2002                          /s/  Kenneth  Barr
                                                    ------------------
                                            Ken  Barr,  Chief  Executive Officer



                             CERTIFICATE PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                               SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

In  connection  with  the  Quarterly Report of Security  Biometrics, Inc.,  (the
"Company")  on Form 10-QSB for the three month period ended  September 30, 2002,
as  filed  with the  Securities and Exchange Commission  on the date hereof (the
"Report"), we certify pursuant to 18 U.S.C. (S) 1350, as adopted pursuant to (S)
906  of  the Sarbanes-Oxley  Act  of  2002,  that:

     1. The Report fully complies with the requirements of Section 13 (a) of the
        Securities  Exchange  Act  of  1934;  and

     2. The  information contained in the Report fairly presents,in all material
        respects,  the  financial  condition  and  results  of  operation of the
        Company.


     Date:  November  12,  2002                     /s/  David  Alexander
                                                    ---------------------
                                        David Alexander, Chief Financial Officer




                                                                        PAGE 24

<PAGE>

                             CERTIFICATE PURSUANT TO
                                   SECTION 302,
                                     OF THE
                           SARBANES-OXLEY ACT OF 2002

I,  Kenneth  Barr,  certify  that:
     1.  I  have  reviewed  this  quarterly  report  on  Form 10-QSB of Security
     Biometrics  Inc.;

     2. Based on my knowledge, this quarterly report does not contain any untrue
     statement  of a material fact or omit to state a material fact necessary to
     make  the  statements  made, in light of the circumstances under which such
     statements  were made, not misleading with respect to the period covered by
     this  quarterly  report;

     3.  Based  on  my  knowledge, the financial statements, and other financial
     information  included  in  this  quarterly  report,  fairly  present in all
     material  respects  the financial condition, results of operations and cash
     flows  of  the  registrant  as  of,  and for, the periods presented in this
     quarterly  report.

     4.  The  registrant's  other  certifying  officer and I are responsible for
     establishing and maintaining disclosure controls and procedures (as defined
     in  Exchange  Act  Rules  13a-14  and  15d-14) for the registrant and have:

          a.  Designed  such  disclosure  controls and procedures to ensure that
          material  information  relating  to  the  registrant,  including  its
          consolidated  subsidiaries,  is  made known to us by others with those
          entities,  particularly  during  the  period  in  which this quarterly
          report  is  being  prepared;

          b. Evaluated the effectiveness of the registrant's disclosure controls
          and procedures as of a date within 90 days prior to the filing date of
          this  quarterly  report  (the  "Evaluation  Date");  and

          c.  Presented  in  this  quarterly  report  our  conclusions about the
          effectiveness  of  the disclosure controls and procedures based on our
          evaluations  as  of  the  Evaluation  Date;

     5. The registrant's other certifying officer and I have disclosed, based on
     our most recent evaluation, to the audit committee of registrant's board of
     directors:

          a.  All  significant  deficiencies  in  the  design  and  operation of
          internal  controls  which  could  adversely  affect  the  registrant's
          ability  to  record,  process, summarize and report financial data and
          have  identified  for  the  registrant's  audit committee any material
          weaknesses  in  internal  controls;  and

          b.  Any  fraud,  whether  or not material, that involves management or
          other  employees  who  have  a  significant  role  in the registrant's
          internal  controls;  and

     6.  The  registrant's other certifying officer and I have indicated in this
     quarterly  report  whether  there  were  significant  changes  in  internal
     controls  or  in  other  factors  that  could significantly affect internal
     controls  subsequent  to  the date of our most recent evaluation, including
     any corrective actions with regard to significant deficiencies and material
     weaknesses.


     Date:  November  21,  2002             /s/  Ken  Barr
                                            -----------------------------------
                                            Ken  Barr,  Chief Executive Officer


                                                                        PAGE 25

<PAGE>

                             CERTIFICATE PURSUANT TO
                                   SECTION 302,
                                     OF THE
                           SARBANES-OXLEY ACT OF 2002

I,  David  Alexander,  certify  that:
     1.  I  have  reviewed  this  quarterly  report  on  Form 10-QSB of Security
     Biometrics  Inc.;

     2. Based on my knowledge, this quarterly report does not contain any untrue
     statement  of a material fact or omit to state a material fact necessary to
     make  the  statements  made, in light of the circumstances under which such
     statements  were made, not misleading with respect to the period covered by
     this  quarterly  report;

     3.  Based  on  my  knowledge, the financial statements, and other financial
     information  included  in  this  quarterly  report,  fairly  present in all
     material  respects  the financial condition, results of operations and cash
     flows  of  the  registrant  as  of,  and for, the periods presented in this
     quarterly  report.

     4.  The  registrant's  other  certifying  officer and I are responsible for
     establishing and maintaining disclosure controls and procedures (as defined
     in  Exchange  Act  Rules  13a-14  and  15d-14) for the registrant and have:

          a.  Designed  such  disclosure  controls and procedures to ensure that
          material  information  relating  to  the  registrant,  including  its
          consolidated  subsidiaries,  is  made known to us by others with those
          entities,  particularly  during  the  period  in  which this quarterly
          report  is  being  prepared;

          b. Evaluated the effectiveness of the registrant's disclosure controls
          and procedures as of a date within 90 days prior to the filing date of
          this  quarterly  report  (the  "Evaluation  Date");  and

          c.  Presented  in  this  quarterly  report  our  conclusions about the
          effectiveness  of  the disclosure controls and procedures based on our
          evaluations  as  of  the  Evaluation  Date;

     5. The registrant's other certifying officer and I have disclosed, based on
     our most recent evaluation, to the audit committee of registrant's board of
     directors:

          a.  All  significant  deficiencies  in  the  design  and  operation of
          internal  controls  which  could  adversely  affect  the  registrant's
          ability  to  record,  process, summarize and report financial data and
          have  identified  for  the  registrant's  audit committee any material
          weaknesses  in  internal  controls;  and

          b.  Any  fraud,  whether  or not material, that involves management or
          other  employees  who  have  a  significant  role  in the registrant's
          internal  controls;  and

     6.  The  registrant's other certifying officer and I have indicated in this
     quarterly  report  whether  there  were  significant  changes  in  internal
     controls  or  in  other  factors  that  could significantly affect internal
     controls  subsequent  to  the date of our most recent evaluation, including
     any corrective actions with regard to significant deficiencies and material
     weaknesses.

     Date:  November  21,  2002         /s/  Ken  Barr
                                        -----------------------------------
                                        David Alexander, Chief Financial Officer


                                                                        PAGE 26
<PAGE>